SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-001604
Filing Date
2024-02-14
Accepted
2024-02-14 09:18:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 PMV PHARMACEUTICALS, INC. p24-0288sc13ga.htm SC 13G/A 56239
  Complete submission text file 0000902664-24-001604.txt   57894
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

IRS No.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91714 | Film No.: 24633016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)